
Carazolol-d7
CAS No. 1173021-02-7
Carazolol-d7( (±)-Carazolol-d7; DL-Carazolol-d7; Suacron-d7 )
Catalog No. M29637 CAS No. 1173021-02-7
Carazolol-d7 is the deuterium labeled Carazolol.Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 172 | In Stock |
![]() ![]() |
10MG | 318 | In Stock |
![]() ![]() |
25MG | 638 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCarazolol-d7
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarazolol-d7 is the deuterium labeled Carazolol.Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process.
-
DescriptionCarazolol-d7 is the deuterium labeled Carazolol.Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
-
In VitroStable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
-
In Vivo——
-
Synonyms(±)-Carazolol-d7; DL-Carazolol-d7; Suacron-d7
-
PathwayNeuroscience
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1173021-02-7
-
Formula Weight305.42
-
Molecular FormulaC18H15D7N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[2H]C([2H])([2H])C(C([2H])([2H])[2H])([2H])NCC(O)COC1=C2C3=CC=CC=C3NC2=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
molnova catalog



related products
-
Terazosin
Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist.
-
Mabuterol-d9
Mabuterol-d9 is a deuterium labeled Mabuterol. Mabuterol is an agonist of the β2-adrenergic receptor.
-
Dapoxetine
A specialty product for proteomics research.